The purpose of these studies was to study patients with abnormal host defense. In FY '93 studies focused on patients with abnormal phagocyte function. Particular emphasis was given to patients with chronic granulomatous diseases of childhood (CGD), who continue to be the subject of intense study. Other diseases that were studied include the Hyperimmunoglobulin-E recurrent infection (Job's) syndrome, neutrophil specific granule deficiency, leukocyte adhesion deficiency and other patients with recurrent infections who do not fall into a specifically defined disease category. Clinical investigations included: (a) description of a patient with """"""""leaky leukocyte syndrome,"""""""" a new disorder characterized by pyoderma gangrenosum in which circulating neutrophils spontaneous release enormous amounts of specific granule contents into the plasma (b) discovery of a patient whith chronic infection with atypical mycobacteria who has absence of a subpopulation of neutrophils that bind the monoclonal antibody C10, and (c) continuation of a phase 4 study evaluating long term effects of interferon-gamma in CGD. We continue to monitor and expand these cohorts of patients who serve as models for long term studies of the immunological manipulation of the abnormal host defenses and for studies developing gene therapy of immune deficiencies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000155-18
Application #
3768735
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
18
Fiscal Year
1993
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Sobhanie, Mahdee; Matsuoka, Yumiko; Jegaskanda, Sinthujan et al. (2016) Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). J Infect Dis 213:922-9
O'Donnell, Christopher D; Vogel, Leatrice; Matsuoka, Yumiko et al. (2014) The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. J Virol 88:12374-84
Baz, Mariana; Luke, Catherine J; Cheng, Xing et al. (2013) H5N1 vaccines in humans. Virus Res 178:78-98
Talaat, Kawsar R; Karron, Ruth A; Luke, Catherine J et al. (2011) An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine 29:3144-8
Kuhns, Douglas B; Alvord, W Gregory; Heller, Theo et al. (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363:2600-10
Talaat, Kawsar R; Karron, Ruth A; Callahan, Karen A et al. (2009) A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 27:3744-53
Karron, Ruth A; Talaat, Kawsar; Luke, Catherine et al. (2009) Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 27:4953-60
Suguitan Jr, Amorsolo L; Marino, Michael P; Desai, Purvi D et al. (2009) The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus. Virology 395:280-8
Zarember, Kol A; Cruz, Anna R; Huang, Chiung-Yu et al. (2009) Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus. Antimicrob Agents Chemother 53:2654-6
De Ravin, Suk See; Shum, Elaine; Zarember, Kol A et al. (2008) Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone. J Pediatr Endocrinol Metab 21:1057-63

Showing the most recent 10 out of 30 publications